医学
淋巴瘤
癌症
肿瘤科
重症监护医学
免疫学
内科学
标识
DOI:10.1056/nejmcibr2203616
摘要
Modified autologous T cells have been successfully used to treat tumors in a small proportion of patients. How can this general approach be used to treat more patients? A recent study of lymphoma, modeled in vitro, points to a potential approach.
科研通智能强力驱动
Strongly Powered by AbleSci AI